Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hempdocon Sep 16, 2020 12:44am

169 Views

Post# 31565319

RE:RE:RE:M D Anderson

At this point, anywhere in Texas would be nice ; )
More seriously, MD Anderson (being a top cancer center in the US) would be a nice crown atop our clinical trials, & considering Dr. Kamat is on our MSAB, I'd be surprised if MD Anderson isn't on our list. But if not, it wouldn't necessarily be a big loss. There are 71 NCI-designated cancer centers in the US across 36 states, so there's a lot of reliable quality to partner with...Roswell Park would be a welcomed surprise & a big plus considering their experience/familiarity with PDT/TLD-1433. RP was also one of the first NCI cancer centers in the US. For the US, it will be more about data results than site results. Good luck...

Bullboard Posts

HPQ Silicon updates shareholders on Fumed Silica Reactor developments